Please read the attached article and answer the following questions, Thank you!
1) What are the causes of the central problems outlined in the case?
2) How should the pharmaceutical companies respond to the crisis without undermining their business and growth strategies?
– What strategy should they follow to protect their intellectual property rights?
– How far should they be willing to go?
– What are the costs and benefits?
